ReviewBiomedicines2022

Efficacy and Safety of Topical Mechanistic Target of Rapamycin Inhibitors for Facial Angiofibromas in Patients with Tuberous Sclerosis Complex: A Systematic Review and Network Meta-Analysis.

Yu-Ting Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.